Journal of Surgical Research
Volume 157, Issue 1 , Pages e23-e29 , November 2009

Topical Heparin: A Promising Agent for the Prevention of Tracheal Stenosis in Airway Surgery

  • Serdar Sen, M.D.

      Affiliations

    • Department of Thoracic Surgery, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Department of General Thoracic Surgery, Adnan Menderes University, Hospital Street, Aydin, Turkey 09100.
    • ,
  • Ibrahim Meteoglu, M.D.

      Affiliations

    • Department of Pathology, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey
    • ,
  • Mustafa Ogurlu, M.D.

      Affiliations

    • Department of Anesthesiology and Reanimation, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey
    • ,
  • Selda Sen, M.D.

      Affiliations

    • Department of Anesthesiology and Reanimation, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey
    • ,
  • Onur Ozgun Derinceoz, Ph.D.

      Affiliations

    • Department of Surgery, Faculty of Veterinary Medicine, Adnan Menderes University, Aydin, Turkey
    • ,
  • Sabri Barutca, M.D.

      Affiliations

    • Department of Medical Oncology, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey

Received 15 November 2008

References 

  1. Perepelitsyn I, Shapshay SM. Endoscopic treatment of laryngeal and tracheal stenosis-has mitomycin C improved the outcome?. Otolaryngol Head Neck Surg. 2004;131:16–20
  2. Ubell ML, Ettema SL, Toohill RJ, et al. Mitomycin-C application in airway stenosis surgery: Analysis of safety and costs. Otolaryngol Head Neck Surg. 2006;134:403
  3. Dodge-Khatami A, Backer CL, Holinger LD, et al. Healing of a free tracheal autograft is enhanced by topical vascular endothelial growth factor in an experimental rabbit model. J Thorac Cardiovasc Surg. 2001;122:554
  4. Cincik H, Güngör A, Cekin E, et al. Effects of topical application of mitomycin-C and 5-fluorouracil on myringotomy in rats. Otol Neurotol. 2005;26:351
  5. Correa AJ, Reinisch L, Sanders DL, et al. Inhibition of subglottic stenosis with mitomycin-C in the canine model. Ann Otol Rhinol Laryngol. 1999;108:1053
  6. Arbag H, Avunduk MC, Ozer B, et al. Increased expression of epidermal growth factor receptors in the tracheal epithelia after topical mitomycin-C in rabbits. Auris Nasus Larynx. 2005;32:65
  7. Eliashar R, Eliachar I, Esclamado R, et al. Can topical mitomycin prevent laryngotracheal stenosis?. Laryngoscope. 1999;109:1594
  8. Rahbar R, Shapshay SM, Healy GB. Mitomycin: Effects on laryngeal and tracheal stenosis, benefits, and complications. Ann Otol Rhinol Laryngol. 2001;110:1
  9. Rahbar R, Jones DT, Nuss RC, et al. The role of mitomycin in the prevention and treatment of scar formation in the pediatric aerodigestive tract: Friend or foe?. Arch Otolaryngol Head Neck Surg. 2002;128:401
  10. Spector JE, Werkhaven JA, Spector NC, et al. Prevention of anterior glottic restenosis in a canine model with topical mitomycin-C. Ann Otol Rhinol Laryngol. 2001;110:1007
  11. Iñiguez-Cuadra R, San Martín Prieto J, Iñiguez-Cuadra M, et al. Effect of mitomycin in the surgical treatment of tracheal stenosis. Arch Otolaryngol Head Neck Surg. 2008;7:709
  12. Lee AY, Rickles FR, Julian JA, et al. Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism. J Clin Oncol. 2005;23:2123
  13. Elsayed E, Becker RC. The impact of heparin compounds on cellular inflammatory responses: A construct for future investigation and pharmaceutical development. J Thromb Thrombolysis. 2003;15:11
  14. Bowler SD, Smith SM, Lavercombe PS. Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects. Am Rev Respir Dis. 1993;147:160
  15. Ang YS, Mahmud N. Randomized comparison of unfractionated heparin in severe active inflammatory bowel disease. Ailment Pharmacol Ther. 2000;14:1015
  16. Folwaczny C, Frick H, Hartman G. Anti-inflammatory properties of unfractionated heparin in patients with highly active ulcerative colitis. AJ Gastroenterol. 1997;92:5
  17. Fries W, Pagiaro E, Canova E, et al. The effect of heparin on trinitrobenzene sulphonic acid-induced colitis in the rat. Aliment Parmacal Ther. 1998;12:229
  18. Oremus M, Hanson MD, Whitlock R, et al. A systematic review of heparin to treat burn injury. J Burn Care Res. 2007;28:794
  19. Nakanishi R, Kawahara K, Takachi T, et al. Early histopathologic features of tracheal allograft rejection: Study in non-immunosuppressed dogs. Transplant Proc. 1994;26:3715
  20. Roh JL, Kim DH, Rha KS, et al. Benefits and risks of mitomycin use in the traumatized tracheal mucosa. Otolaryngol Head Neck Surg. 2007;136:459
  21. Hueman EM, Simpson CB. Airway complications from topical mitomycin C. Otolaryngol Head Neck Surg. 2005;133:831
  22. Simpson CB, James JC. The efficacy of mitomycin-C in the treatment of laryngotracheal stenosis. Laryngoscope. 2006;116:1923
  23. Frucht-Pery J, Siganos CS, Ilsar M. Intraoperative application of topical mitomycin C for pterygium surgery. Ophthalmology. 1996;103:674
  24. Rubinfeld RS, Stein RM. Topical mitomycin-C for pterygia: Is single application appropriate?. Ophthalmic Surg Lasers. 1997;28:662
  25. Chan KO, Gervais M, Tsaparas Y, et al. Effectiveness of intraoperative mitomycin C in maintaining the patency of a frontal sinusotomy: A preliminary report of a double-blind randomized placebo controlled trial. Am J Rhinol. 2006;20:295
  26. Rahman A, Channa S, Niazi JH, et al. Dacryocystorhinostomy without intubation with intraoperative mitomycin-C. J Coll Phys Surg Pak. 2006;16:476
  27. Hartnick CJ, Hartley BEJ, Lacy PD, et al. Topical mitomycin application after laryngotracheal reconstruction. Arch Otolaryngol Head Neck Surg. 2001;127:1260
  28. Hardillo J, Vanclooster C, Delaere PR. An investigation of airway wound healing using a novel in vivo model. Laryngoscope. 2003;113:237
  29. Correa AJ, Reinish L, Sanders DL, et al. Inhibition of subglottic stenosis with mitomycin-C in the canine model. Ann Otol Rhinol Laryngol. 1999;108:1053
  30. Unal M. The successful management of congenital laryngeal web with endoscopic lysis and topical mitomycin-C. Int J Pediatr Otorhinolaryngol. 2004;68:231
  31. Ward RF, April MM. Mitomycin-C in the treatment of tracheal cicatrix after tracheal reconstruction. Int J Pediatr Otorhinolaryngol. 1998;44:221
  32. Gray SD, Tritle N, Li W. The effect of mitomycin on extracellular matrix proteins in a rat wound model. Laryngoscope. 2003;113:237
  33. Cham G, Pan JC, Lim F, et al. Effects of topical heparin, antivenom, tetracycline and dexamethasone treatment in corneal injury resulting from the venom of the black spitting cobra (Naja sumatrana), in a rabbit model. Clin Toxicol (Phila). 2006;44:287
  34. Gaffney A, Gaffney P. Rheumatoid arthritis and heparin. Br J Rheumatol. 1996;35:808
  35. Bowler SD, Smith SM, Lavercombe PS. Heparin inhibits the immediate response to antigen in the skin and lungs of allergic subjects. Am Rev Respir Dis. 1993;147:160
  36. Fan SQ, Qin LY, Cai JL, et al. Effect of heparin on production of basic fibroblast growth factor and transforming growth factor-beta1 by human normal skin and hyperplastic scar fibroblasts. J Burn Care Res. 2007;28:734
  37. Saliba MJ. Heparin in the treatment of burns: A review. Burns. 2001;27:349
  38. Kratz G, Back M, Arnander C, et al. Immobilized heparin accelerates the healing of human wounds in vivo. Scand J Plast Reconstr Surg Hand Surg. 1998;32:381
  39. Górski G, Szopiński P, Michalak J, et al. Liposomal heparin spray: A new formula in adjunctive treatment of superficial venous thrombosis. Angiology. 2005;56:9
  40. Vecchio C, Frisinghelli A. Topically applied heparins for the treatment of vascular disorders: A comprehensive review. Clin Drug Investig. 2008;28:603

PII: S0022-4804(09)00035-3

doi: 10.1016/j.jss.2009.01.028

Journal of Surgical Research
Volume 157, Issue 1 , Pages e23-e29 , November 2009

Article Tools

* Image Usage & Resolution